NORMA CANO: Open Payments
NPI 1568798254 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 47 payments from 9 companies in 2025. Trend: 2023 $641 · 2024 $493 · 2025 $1,142
Food & beverage: $1,142
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $361 |
| PFIZER INC. | 11 | $309 |
| AstraZeneca Pharmaceuticals LP | 5 | $200 |
| Exact Sciences Corporation | 8 | $145 |
| SHIELD THERAPEUTICS INC | 3 | $56 |
| Lilly USA, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Ozempic, FARXIGA, NURTEC ODT, The Cologuard Plus Collection Kit, ZAVZPRET, PREVNAR 20, Rybelsus, ACCRUFER.
Industry payments across NC — which companies pay providers there.
